user

Systemic palliative treatment in patients with metastatic colorectal cancer tested for their (K)RAS mutation status - Real-life data from the clinical Tumour Registry Colorectal Cancer (TKK)

被引：0
|
作者：
Zahn, M. O. [1 ]
Schnell, R. [2 ]
Karcher, A. [3 ]
Schnitzler, M. [4 ]
Wetzel, N. [4 ]
Fleitz, A. [4 ]
Marschner, N. [5 ]
机构：
[1] Studienzentrum MVZ Onkol Kooperat Harz, Goslar, Germany
[2] PIOH, Frechen, Germany
[3] Onkol Schwerpunktpraxis, Heidelberg, Germany
[4] iOMEDICO, Freiburg, Germany
[5] Praxis Interdisziplinare Onkol & Hamatol, Freiburg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2016年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V171
引用
收藏
页码：42 / 42
页数：1
相关论文
共 50 条
  • [41] Metastatic colorectal cancer prior to expanded RAS assessment: evidence from long-term outcome analysis of a real-life cohort within a dedicated colorectal cancer unit
    Luca Bertero
    Rosella Spadi
    Simona Osella-Abate
    Sara Mariani
    Isabella Castellano
    Alessandro Gambella
    Patrizia Racca
    Mario Morino
    Paola Cassoni
    World Journal of Surgical Oncology, 18
  • [42] Metastatic colorectal cancer prior to expanded RAS assessment: evidence from long-term outcome analysis of a real-life cohort within a dedicated colorectal cancer unit
    Bertero, Luca
    Spadi, Rosella
    Osella-Abate, Simona
    Mariani, Sara
    Castellano, Isabella
    Gambella, Alessandro
    Racca, Patrizia
    Morino, Mario
    Cassoni, Paola
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2020, 18 (01)
  • [43] REVIEW OF THE CURRENT STATUS OF RAS MUTATION TESTING IN PATIENTS WITH METASTATIC COLORECTAL CANCER (MCRC): FLASH-RAS STUDY
    Longin, J.
    VALUE IN HEALTH, 2015, 18 (07) : A491 - A491
  • [44] K-ras gene mutations in normal colorectal tissues from K-ras mutation-positive colorectal cancer patients
    Zhu, D
    Keohavong, P
    Finkelstein, SD
    Swalsky, P
    Bakker, A
    Weissfeld, J
    Srivastava, S
    Whiteside, TL
    CANCER RESEARCH, 1997, 57 (12) : 2485 - 2492
  • [45] Clinical impact of K-ras mutation in colorectal cancer patients treated with adjuvant FOLFOX
    Chang, Myung Hee
    Lee, In Kyu
    Si, Yoon
    Lee, Kyu Sang
    Woo, In-Sook
    Byun, Jae Ho
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (02) : 317 - 323
  • [46] Clinical impact of K-ras mutation in colorectal cancer patients treated with adjuvant FOLFOX
    Myung Hee Chang
    In Kyu Lee
    Yoon Si
    Kyu Sang Lee
    In-Sook Woo
    Jae Ho Byun
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 317 - 323
  • [47] Outcomes and predictive factors of regorafenib benefit in patients with metastatic colorectal cancer in a real-life setting
    Martinez Lago, N.
    Carnero Lopez, B.
    De la Camara Gomez, J.
    Vazquez-Rivera, F.
    Fernandez Montes, A.
    de Dios, N.
    Carral Maseda, A.
    Pellon Augusto, M.
    Candamio Folgar, S.
    Reboredo-Lopez, M.
    Salgado Fernandez, M.
    Gallardo Martin, E.
    Covela-Rua, M.
    Grana Suarez, B.
    Carmona Campos, M.
    Brozos Vazquez, E.
    Reboredo Rendo, C.
    Quintero Aldana, G.
    Grande Ventura, C.
    Vidal Insua, Y.
    Mendez Mendez, J.
    ANNALS OF ONCOLOGY, 2020, 31 : S130 - S130
  • [48] How are elderly patients treated after a diagnosis of metastatic colorectal cancer in real-life practice?
    Gouverneur, A.
    Rouyer, M.
    Grelaud, A.
    Colombani, F.
    Terrebonne, E.
    Smith, D.
    Fourrier-Reglat, A.
    Noize, P.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2015, 29 : 71 - 72
  • [49] RAS/RAF mutation status in Algerian patients with metastatic colorectal cancer (mCRC) and impact of the primary site on clinical and prognostic outcomes
    Djounidi, A.
    Merair, N.
    ANNALS OF ONCOLOGY, 2023, 34 : S147 - S147
  • [50] RAS mutation prevalence among patients with metastatic colorectal cancer: A meta-analysis of real-world data.
    Kafatos, George
    Lowe, Kimberly
    Jenkins-Anderson, Sophie
    Garawin, Tamer
    Traugottova, Zuzana
    Bilalis, Antonios
    Molnar, Edit
    Wieruszewska-Kowalczyk, Karolina
    Niepel, Daniela
    van Krieken, J. Han
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
12345